Ignite Creation Date:
2024-05-05 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 9:40 AM
Study NCT ID:
NCT00590291
Status:
TERMINATED
Last Update Posted:
2021-05-17
First Post:
2007-12-27
Brief Title:
Molecular Determinants of Coronaruy Artery Disease
Sponsor:
Organization:
The Cleveland Clinic
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
For each participant 10 ml of blood for lymphoblastoid cell line immortalization 10-20 ml blood for DNA extraction or two buccal swabs If gene identified blood samples from children to identify the children affected with this gene will be obtained When available biopsy tissues for extracting DNA RNA protein or for cell biological studies will be obtained Human genomic DNA will be prepared from peripheral blood lymphocytes biopsy tissue or cell lines derived from Epstein Barr virus transformed lymphocytes 15 DNA will be used for a variety of purposes including linkage analysis and mutational screening
Enrollment Count:
1461
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Family-Based |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 4654 |
Who Masked List: